Attention deficit hyperactivity disorder treatment practice in Turkey
Yıl: 2016 Cilt: 26 Sayı: 3 Sayfa Aralığı: 265 - 272 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022
Attention deficit hyperactivity disorder treatment practice in Turkey
Öz: Objective: To determine the factors associated with type of ADHD prescription and re-admission of the cases to the outpatient clinics between January-July 2013. Method: The Ministry of Health prescription database, which included prescriber, region, age and gender data and contained almost 20% of IMS data. Results: A total of 73,189 prescription were prescribed to a total of 41,341 (30,014 males; 72.7%) patients. 38645 (93.5%) of the patients were between 6 and 18 years of age. The most frequently prescribed drug was OROS methylphenidate (MPH, 59.7%) followed by IR MPH, atomoxetine and combination of drugs. There were several regional differences in prescription practice. Treatment choice changed significantly with age and gender. Rate of repeated prescription was highest among 6-18 year-old male subjects receiving combination treatment. Conclusions: ADHD treatment choice seemed to be heavily influenced by official regulations. Age, gender and drug of choice were important factors associated with treatment adherence.
Anahtar Kelime: Konular:
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Oner O, Yilmaz ES, Karadag H, Vural M, Vural EH, Akbulat A, Gursoz H, Turkcapar H, Kerman S. ADHD Medication Trends in Turkey: 2009-2013. J Atten Disord. 2014, [Epub ahead of print] [CrossRef]2. Hodgkins P, Sasané R, Meijer WM. Pharmacologic treatment of attention-deficit/hyperactivity disorder in children: incidence, prevalence, and treatment patterns in the Netherlands. Clin Ther 2011;33(2):188-203. [CrossRef]3. Trece-o C, Martín Arias LH, Sáinz M, Salado I, García Ortega P, Velasco V, et al. Trends in the consumption of attention deficit hyperactivity disorder medications in Castilla y León (Spain): changes in the consumption pattern following the introduction of extended release methylphenidate. Pharmacoepidemiol Drug Saf 2012;21(4):435-41. [CrossRef]4. Prosser B, Reid R. Changes in use of psychostimulant medication for ADHD in South Australia (1990-2006). Aust N Z J Psychiatry 2009;43(4):340-7. [CrossRef] . Steinhausen HC, Bisgaard C. Nationwide time trends in dispensed prescriptions of psychotropic medication for children and adolescents in Denmark. Acta Psychiatr Scand 2014;129(3):221-31. [CrossRef]6. Zuvekas SH, Vitiello B. Stimulant medication use in children: a 12-year perspective. Am J Psychiatry 2012;169(2):160-6. [CrossRef]7. Schirm E, Tobi H, Zito JM, de Jong-van den Berg LT. Psychotropic medication in children: a study from the Netherlands. Pediatrics 2001;108(2):E25. [CrossRef]8. Knellwolf AL, Deligne J, Chiarotti F, Auleley GR, Palmieri S, Boisgard CB, et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol 2008;64(3):311-7. [CrossRef]9. Trip AM, Visser ST, Kalverdijk LJ, de Jong-van den Berg LT. Large increase of the use of psycho-stimulants among youth in the Netherlands between 1996 and 2006. Br J Clin Pharmacol 2009;67(4):466-8. [CrossRef]10. Wilens TE, Adler LA, Adams J, Sgambati S, Rotrosen J, Sawtelle R, et al. Misuse and diversion of stimulants prescribed for ADHD: a systematic review of the literature. J Am Acad Child Adolesc Psychiatry 2008;47(1):21-31. [CrossRef]11. Weyandt LL, Marraccini ME, Gudmundsdottir BG, Zavras BM, Turcotte KD, Munro BA, et al. Misuse of prescription stimulants among college students: a review of the literature and implications for morphological and cognitive effects on brain functioning. Exp Clin Psychopharmacol 2013;21(5):385-407. [CrossRef]12. Angold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 2000;39(8):975-84. [CrossRef]13. Hoagwood K, Kelleher KJ, Feil M, Comer DM. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 2000;39(2):198-206. [CrossRef]14. Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA. Use of medication by young people with attention-deficit/hyperactivity disorder. Med J Aust 2002;177(1):21-5.15. Tremmery S, Buitelaar JK, Steyaert J, Molenberghs G, Feron FJ, Kalff AC, et al. The use of health care services and psychotropic medication in a community sample of 9-year-old schoolchildren with ADHD. Eur Child Adolesc Psychiatry 2007;16 (5):327-36. [CrossRef]16. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998;155(4):493-8. [CrossRef]17. Lee SS, Humphreys KL, Flory K, Liu R, Glass K. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011;31(3):328-41. [CrossRef]18. Klein RG, Mannuzza S, Olazagasti MA, Roizen E, Hutchison JA, Lashua EC, et al. Clinical and functional outcome of childhood attention-deficit/hyperactivity disorder 33 years later. Arch Gen Psychiatry 2012;69(12):1295-303. [CrossRef]19. Robb A, Findling RL. Challenges in the transition of care for adolescents with attention-deficit/hyperactivity disorder. Postgrad Med 2013;125(4):131-40. [CrossRef]20. Hall CL, Newell K, Taylor J, Sayal K, Swift KD, Hollis C. 'Mind the gap'--mapping services for young people with ADHD transitioning from child to adult mental health services. BMC Psychiatry 2013;13:186. [CrossRef]21. Faraone SV, Glatt SJ. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. J Clin Psychiatry 2010;71(6):754-63. [CrossRef]22. Pottegard A, Bjerregaard BK, Glintborg D, Kortegaard LS, Hallas J, Moreno SI. The use of medication against attention deficit/hyperactivity disorder in Denmark: a drug use study from a patient perspective. Eur J Clin Pharmacol 2013;69(3):589-98. [CrossRef]23. Charach A, Fernandez R. Enhancing ADHD medication adherence: challenges and opportunities. Curr Psychiatry Rep 2013;15(7):371. [CrossRef]24. Greenhill L, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, et al. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry 2006;45(11):1284-93. [CrossRef]
| APA | ÖNER Ö, Turkcapar M, ISLİ F, karadağ h, AKBULAT A, BASCİ A, Aksoy M, SECKİN C, Alkan A (2016). Attention deficit hyperactivity disorder treatment practice in Turkey. , 265 - 272. |
| Chicago | ÖNER Özgür,Turkcapar Mehmet Hakan,ISLİ Fatma,karadağ hasan,AKBULAT Akif,BASCİ Ali Boray,Aksoy Mesil,SECKİN Cem,Alkan Ali Attention deficit hyperactivity disorder treatment practice in Turkey. (2016): 265 - 272. |
| MLA | ÖNER Özgür,Turkcapar Mehmet Hakan,ISLİ Fatma,karadağ hasan,AKBULAT Akif,BASCİ Ali Boray,Aksoy Mesil,SECKİN Cem,Alkan Ali Attention deficit hyperactivity disorder treatment practice in Turkey. , 2016, ss.265 - 272. |
| AMA | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A Attention deficit hyperactivity disorder treatment practice in Turkey. . 2016; 265 - 272. |
| Vancouver | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A Attention deficit hyperactivity disorder treatment practice in Turkey. . 2016; 265 - 272. |
| IEEE | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A "Attention deficit hyperactivity disorder treatment practice in Turkey." , ss.265 - 272, 2016. |
| ISNAD | ÖNER, Özgür vd. "Attention deficit hyperactivity disorder treatment practice in Turkey". (2016), 265-272. |
| APA | ÖNER Ö, Turkcapar M, ISLİ F, karadağ h, AKBULAT A, BASCİ A, Aksoy M, SECKİN C, Alkan A (2016). Attention deficit hyperactivity disorder treatment practice in Turkey. Klinik Psikofarmakoloji Bülteni, 26(3), 265 - 272. |
| Chicago | ÖNER Özgür,Turkcapar Mehmet Hakan,ISLİ Fatma,karadağ hasan,AKBULAT Akif,BASCİ Ali Boray,Aksoy Mesil,SECKİN Cem,Alkan Ali Attention deficit hyperactivity disorder treatment practice in Turkey. Klinik Psikofarmakoloji Bülteni 26, no.3 (2016): 265 - 272. |
| MLA | ÖNER Özgür,Turkcapar Mehmet Hakan,ISLİ Fatma,karadağ hasan,AKBULAT Akif,BASCİ Ali Boray,Aksoy Mesil,SECKİN Cem,Alkan Ali Attention deficit hyperactivity disorder treatment practice in Turkey. Klinik Psikofarmakoloji Bülteni, vol.26, no.3, 2016, ss.265 - 272. |
| AMA | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A Attention deficit hyperactivity disorder treatment practice in Turkey. Klinik Psikofarmakoloji Bülteni. 2016; 26(3): 265 - 272. |
| Vancouver | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A Attention deficit hyperactivity disorder treatment practice in Turkey. Klinik Psikofarmakoloji Bülteni. 2016; 26(3): 265 - 272. |
| IEEE | ÖNER Ö,Turkcapar M,ISLİ F,karadağ h,AKBULAT A,BASCİ A,Aksoy M,SECKİN C,Alkan A "Attention deficit hyperactivity disorder treatment practice in Turkey." Klinik Psikofarmakoloji Bülteni, 26, ss.265 - 272, 2016. |
| ISNAD | ÖNER, Özgür vd. "Attention deficit hyperactivity disorder treatment practice in Turkey". Klinik Psikofarmakoloji Bülteni 26/3 (2016), 265-272. |
